https://www.selleckchem.com/products/bmn-673.html
Here, we will discuss computational approaches to identify and validate robust biomarkers of changed tissue homeostasis using cell-free, methylated DNA in the circulation. We highlight studies performing genome-wide profiling of cfDNA methylation and those that combine genetic and epigenetic markers to further identify cell-type specific signatures. Finally, we discuss opportunities and current limitations of these approaches for implementation in clinical oncology. Prostate cancer (PCa) is among the leading causes of cancer mortality.
Like
Comment
Share
